ArticleChina CDC weekly2026
First Imported Case of Cerebral Schistosomiasis Mansoni - China, May 2025.
Article in China CDC weekly, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
What is already known about this topic?: What is added by this report?: This report documents the first imported case of cerebral schistosomiasis mansoni in China. We present the epidemiological investigation, distinctive clinical manifestations, diagnostic challenges including misdiagnosis and delayed diagnosis, and the critical role of pathogen detection in case confirmation. What are the implications for public health practice?: With the continuous emergence of imported S. mansoni cases and the gradual expansion of intermediate host breeding grounds, active monitoring should be conducted for potential risks of local transmission within China. To prevent this disease from becoming endemic, CDCs and medical institutions must strengthen their diagnostic, treatment, and prevention capabilities, as well as their monitoring and early warning capacities for imported schistosomiasis mansoni.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.